§ PHARMACEUTICALS
USD · PharmaceuticalsCRMD
CORMEDIX INC
USDSector · PharmaceuticalsBeta · 1.51
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
104 increased/new, 63 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/E | 3.8 | P/B | 2.26 |
| EPS (TTM) | 2.10 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Deep Track Capital, LP | 6.3M | 0.7% | +19% |
| BlackRock, Inc. | 6.0M | 0.0% | +3% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.1M | n/a | n/a |
| State Street | 2.2M | 0.0% | +14% |
| ROYCE & ASSOCIATES LP | 1.9M | 0.1% | +680% |
| Geode Capital Management | 1.8M | 0.0% | −5% |
◇ AC INTELLIGENCE
Top institutional owners for CRMD as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER92.7% · 0 holders
OTHER4.4% · 129 holders
PASSIVE / INDEX1.4% · 10 holders
DEALER / BANK1.0% · 21 holders
QUALITY / COMPOUNDER0.2% · 15 holders
SYSTEMATIC / QUANT0.2% · 6 holders
INCOME / DEFENSIVE0.1% · 11 holders
TACTICAL / MACRO0.1% · 1 holder
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for CRMD in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention CRMD yet.